Facilitating rapid, accurate cell line development
Developing robust and high-yielding cell lines for biotherapeutics is a critical yet challenging process in the field of biotechnology. Traditional cell line development methods, such as limiting dilution and Fluorescence Assisted Cell Sorting (FACS), are often time-consuming, resource-intensive and prone to low success rates due to issues like poor clone viability, inconsistent monoclonality and inefficient resource utilization.
In this Application Note, Sartorius (Göttingen, Germany) details the CellCelector Flex platform, which leverages advanced nanowell technology, automation and bead-based secretion assays, offering a robust alternative to traditional methods.
Complete the form below to download the Application Note.
This Application Note is part of a Spotlight on cell line development. Visit the full feature and discover expert insights on the topic.
This content was provided by Sartorius.
